This is the first in a three-part Cannabis Industry Journal series on the impact of blockchain in the cannabis industry.
Extractors should know these methods exist for helping them protect their intellectual property.
The continent is set to have a booming year, with movements already afoot that promise steady growth in the cannabis sector beginning with this quarter.
Parliament is moved to reconsider the fate of cannabinoid patients as GW Pharma faces uncertain future in epilepsy cannabinoid market
The 4th annual Emerald Conference brought researchers and scientists from around the world to share their findings in San Diego last week.
The battle to approve Israeli medical cannabis for export has hit a snag as Israel’s president bows to Trump’s request to halt the impending trade.
In the first part of this series, we’ll identify the key aspects of a hazard analysis.
The move to brand a targeted cannabinoid treatment for refractory epilepsy is a unique development in an EU market focused on generics.
The addition will further expand IPC’s event capabilities.
Sunrise Genetics announced they have successfully mapped the cannabis genome, the first group to do so.
